---

---

entities : Astrazeneca plc   

save search

---

Orphan Drugs Market Projection: BCC Research Anticipates a Staggering $415.2 Billion Valuation by 2028, Reflecting Soaring Global Demand
Published: 2024-02-09 (Crawled : 10:00) - prnewswire.com
ALPMF | News | $9.75 43.47% 200 |

Health Technology

| -10.96% | O: -0.91% H: 3.88% C: 3.88%
AZNCF | News | $136.2 -4.19% 1.7K |

Health Technology

| 10.98% | O: -2.6% H: 2.26% C: 1.44%
NVSEF | News | $93.6375 6.88% 82K |

Health Technology

| -7.92% | O: -2.46% H: 0.0% C: 0.0%
ALPMY | News | $9.5 -1.11% 1M |

Manufacturing

| -11.18% | O: 4.66% H: 0.0% C: -3.92%
PFE | News A | $26.26 1.0% -0.08% 36M |

Health Technology

| -4.75% | O: -0.04% H: 0.11% C: 0.0%
NVS | News | $95.12 0.81% -1.18% 2.4M |

Health Technology

| -6.5% | O: -0.37% H: 0.21% C: 0.05%
ABBV | News | $167.89 0.89% 0.0% 5.6M |

Health Technology

| -3.74% | O: 0.33% H: 0.0% C: 0.0%
SNY | News | $47.125 1.78% 1.75% 2.1M |

Health Technology

| 0.4% | O: 1.11% H: 0.0% C: 0.0%
AZN | News | $70.12 2.29% 2.24% 4.8M |

Health Technology

| 10.41% | O: -1.28% H: 1.05% C: -0.72%
research global market

---

BioInvent to Evaluate BI-1206 in Combination with Rituximab and Calquence
Published: 2024-02-09 (Crawled : 09:00) - biospace.com/
AZN | News | $70.12 2.29% 2.24% 4.8M |

Health Technology

| 10.41% | O: -1.28% H: 1.05% C: -0.72%
bi-1206

---

Eplontersen granted U.S. FDA Fast Track designation for patients with transthyretin-mediated amyloid cardiomyopathy
Published: 2024-02-08 (Crawled : 12:00) - prnewswire.com
AZNCF | News | $136.2 -4.19% 1.7K |

Health Technology

| 4.04% | O: -8.5% H: 2.46% C: 2.46%
IONS | $41.08 0.98% 0.97% 670K |

Health Technology

| -17.1% | O: 0.2% H: 1.37% C: 0.68%
AZN | News | $70.12 2.29% 2.24% 4.8M |

Health Technology

| 5.38% | O: -6.81% H: 3.02% C: 2.42%
fda granted designation eplontersen

---

Biologic Therapeutics Market to Increase by USD 286.12 billion during 2022-2027, North America to account for 57% of the growth - Technavio
Published: 2024-02-07 (Crawled : 08:00) - prnewswire.com
AZNCF | News | $136.2 -4.19% 1.7K |

Health Technology

| 3.65% | O: -0.37% H: 0.0% C: 0.0%
NVSEF | News | $93.6375 6.88% 82K |

Health Technology

| -7.55% | O: 0.41% H: 0.0% C: 0.0%
NVS | News | $95.12 0.81% -1.18% 2.4M |

Health Technology

| -8.65% | O: 0.09% H: 0.39% C: -0.36%
GSK | News | $40.59 2.11% -0.36% 3.8M |

Health Technology

| -2.78% | O: 0.43% H: 0.67% C: 0.21%
BAX | $40.4 2.36% 0.0% 3.2M |

Health Technology

| 1.74% | O: 0.21% H: 0.24% C: -1.04%
ABBV | News | $167.89 0.89% 0.0% 5.6M |

Health Technology

| -1.83% | O: 1.48% H: 0.0% C: 0.0%
SNY | News | $47.125 1.78% 1.75% 2.1M |

Health Technology

| -0.55% | O: 1.33% H: 0.0% C: 0.0%
BMRN | $89.52 1.0% 0.99% 1.2M |

Health Technology

| -0.35% | O: -0.38% H: 1.79% C: 0.22%
AZN | News | $70.12 2.29% 2.24% 4.8M |

Health Technology

| 4.61% | O: -0.4% H: 0.19% C: -0.33%
AMGN | News | $271.98 1.13% 1.12% 2.1M |

Health Technology

| -13.97% | O: -0.18% H: 0.0% C: -6.22%
america therapeutics growth market

---

Blood Cancer Drugs Market Report 2023: Reveals Striking Growth Prospects with a Surge in R&D Activities - Long-term Forecasts to 2028 and 2033
Published: 2024-02-06 (Crawled : 00:00) - prnewswire.com
ALPMF | News | $9.75 43.47% 200 |

Health Technology

| -12.32% | O: -1.53% H: 0.0% C: 0.0%
AZNCF | News | $136.2 -4.19% 1.7K |

Health Technology

| 3.65% | O: -0.37% H: 0.0% C: 0.0%
NVSEF | News | $93.6375 6.88% 82K |

Health Technology

| -7.55% | O: 0.41% H: 0.0% C: 0.0%
UCBJY | $64.535 -4.38% 3.5K |

Manufacturing

| 38.86% | O: 1.71% H: 1.28% C: 0.94%
ALPMY | News | $9.5 -1.11% 1M |

Manufacturing

| -12.49% | O: 0.28% H: 0.18% C: 0.0%
TAK | News | $13.36 0.91% -0.52% 1.6M |

Health Technology

| -5.65% | O: 0.07% H: 0.42% C: 0.07%
NVS | News | $95.12 0.81% -1.18% 2.4M |

Health Technology

| -8.65% | O: 0.09% H: 0.39% C: -0.36%
JNJ | News | $149.12 0.82% 0.0% 9.3M |

Health Technology

| -4.25% | O: 1.47% H: 0.0% C: 0.0%
LLY | News | $731.33 0.69% 0.0% 2.3M |

Health Technology

| 3.73% | O: 0.76% H: 4.31% C: 2.11%
BMY | $49.14 0.43% 0.0% 7.9M |

Health Technology

| -0.24% | O: -0.14% H: 0.35% C: -1.12%
ABBV | News | $167.89 0.89% 0.0% 5.6M |

Health Technology

| -1.83% | O: 1.48% H: 0.0% C: 0.0%
VRTX | $400.07 1.47% 1.45% 1.3M |

Health Technology

| -4.46% | O: 0.15% H: 2.4% C: 0.56%
SNY | News | $47.125 1.78% 1.75% 2.1M |

Health Technology

| -0.55% | O: 1.33% H: 0.0% C: 0.0%
JAZZ | $108.81 -1.03% -1.04% 510K |

Health Technology

| -12.73% | O: -0.02% H: 0.0% C: -1.4%
AZN | News | $70.12 2.29% 2.24% 4.8M |

Health Technology

| 4.61% | O: -0.4% H: 0.19% C: -0.33%
AMGN | News | $271.98 1.13% 1.12% 2.1M |

Health Technology

| -13.97% | O: -0.18% H: 0.0% C: -6.22%
report cancer blood growth market

---

Genprex Announces First Patient Dosed in Phase 2a Expansion of Acclaim-1 Clinical Study of Reqorsa® Therapy in Combination with Tagrisso® to Treat Non-Small Cell Lung Cancer
Published: 2024-02-05 (Crawled : 12:30) - prnewswire.com
AZNCF | News | $136.2 -4.19% 1.7K |

Health Technology

| 5.18% | O: -0.17% H: 0.09% C: -2.76%
GNPX | $2.15 0.94% 0.93% 19K |

Health Technology

| -63.45% | O: 33.84% H: 1.01% C: -15.3%
AZN | News | $70.12 2.29% 2.24% 4.8M |

Health Technology

| 6.84% | O: -0.76% H: 0.77% C: 0.0%
reqorsa first lung cancer treat cell expansion therapy study

---

Topical Corticosteroids Market to Grow by USD 1.08 billion between 2022 to 2027, globally at 4% CAGR - Technavio
Published: 2024-01-30 (Crawled : 23:00) - prnewswire.com
ALPMF | News | $9.75 43.47% 200 |

Health Technology

| -15.58% | O: 4.34% H: 0.0% C: 0.0%
GLAXF | News | $20.2 -14.18% 510 |

Health Technology

| 5.21% | O: 5.68% H: 0.77% C: 0.77%
AZNCF | News | $136.2 -4.19% 1.7K |

Health Technology

| 5.7% | O: 3.41% H: 0.0% C: -2.45%
ALPMY | News | $9.5 -1.11% 1M |

Manufacturing

| -17.63% | O: 0.0% H: 1.38% C: 0.26%
VTRS | News A | $11.235 -0.13% -0.13% 5.1M |

Health Technology

| -4.74% | O: -0.08% H: 3.47% C: -0.25%
NVS | News | $95.12 0.81% -1.18% 2.4M |

Health Technology

| -12.05% | O: -2.04% H: 0.19% C: -1.97%
GSK | News | $40.59 2.11% -0.36% 3.8M |

Health Technology

| 3.84% | O: 4.04% H: 1.57% C: -3.02%
ABBV | News | $167.89 0.89% 0.0% 5.6M |

Health Technology

| 1.8% | O: 0.5% H: 0.07% C: -0.81%
SNY | News | $47.125 1.78% 1.75% 2.1M |

Health Technology

| -7.95% | O: 1.75% H: 0.0% C: 0.0%
AZN | News | $70.12 2.29% 2.24% 4.8M |

Health Technology

| 4.36% | O: 0.82% H: 0.12% C: -1.64%
market

---

Breast Cancer Therapeutics Market 2023, USD 15.64 billion Growth is Expected between 2023 to 2028, Robust pipeline and new drug approvals to Boost Growth - Technavio
Published: 2024-01-30 (Crawled : 18:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510 |

Health Technology

| 5.21% | O: 5.68% H: 0.77% C: 0.77%
AZNCF | News | $136.2 -4.19% 1.7K |

Health Technology

| 5.7% | O: 3.41% H: 0.0% C: -2.45%
VTRS | News A | $11.235 -0.13% -0.13% 5.1M |

Health Technology

| -4.74% | O: -0.08% H: 3.47% C: -0.25%
NVS | News | $95.12 0.81% -1.18% 2.4M |

Health Technology

| -12.05% | O: -2.04% H: 0.19% C: -1.97%
GSK | News | $40.59 2.11% -0.36% 3.8M |

Health Technology

| 3.84% | O: 4.04% H: 1.57% C: -3.02%
ABBV | News | $167.89 0.89% 0.0% 5.6M |

Health Technology

| 1.8% | O: 0.5% H: 0.07% C: -0.81%
SNY | News | $47.125 1.78% 1.75% 2.1M |

Health Technology

| -7.95% | O: 1.75% H: 0.0% C: 0.0%
PBYI | $5.17 3.19% 3.09% 270K |

Health Technology

| 8.5% | O: -0.1% H: 2.31% C: -1.26%
AZN | News | $70.12 2.29% 2.24% 4.8M |

Health Technology

| 4.36% | O: 0.82% H: 0.12% C: -1.64%
AMGN | News | $271.98 1.13% 1.12% 2.1M |

Health Technology

| -13.58% | O: 0.44% H: 0.2% C: -0.55%
drug breast expected cancer pipeline therapeutics growth market

---

Renal Anemia Therapeutics Market to Record Growth of USD 2.08 billion from 2023 to 2028, Akebia Therapeutics Inc and Amgen Inc to emerge as Some of the Key Companies - Technavio
Published: 2024-01-29 (Crawled : 00:00) - prnewswire.com
CMXHF | $173.25 -19.21% 140 |

n/a

| -10.55% | O: -1.84% H: 0.52% C: 0.52%
CSLLY | $86.918 3.3% 60K |

n/a

| -8.3% | O: -0.25% H: 1.0% C: 0.98%
ALPMF | News | $9.75 43.47% 200 |

Health Technology

| -14.1% | O: 1.76% H: 0.0% C: 0.0%
GLAXF | News | $20.2 -14.18% 510 |

Health Technology

| 7.04% | O: 2.93% H: 0.0% C: -1.15%
AZNCF | News | $136.2 -4.19% 1.7K |

Health Technology

| 4.72% | O: 3.1% H: 0.0% C: -3.91%
ALPMY | News | $9.5 -1.11% 1M |

Manufacturing

| -17.84% | O: -3.53% H: 3.49% C: 3.4%
TVTX | $5.85 2.27% 2.22% 1.1M |

Health Technology

| -37.23% | O: -1.39% H: 0.16% C: -1.96%
GSK | News | $40.59 2.11% -0.36% 3.8M |

Health Technology

| 3.92% | O: 0.26% H: 0.13% C: -0.18%
AZN | News | $70.12 2.29% 2.24% 4.8M |

Health Technology

| 4.38% | O: 0.24% H: 0.01% C: -0.22%
AMGN | News | $271.98 1.13% 1.12% 2.1M |

Health Technology

| -13.25% | O: -0.29% H: 0.76% C: 0.67%
companies renal anemia key therapeutics growth market

---

ENHERTU® Granted Priority Review in the U.S. for Patients with Metastatic HER2 Positive Solid Tumors
Published: 2024-01-29 (Crawled : 11:00) - biospace.com/
AZN | News | $70.12 2.29% 2.24% 4.8M |

Health Technology

| 4.52% | O: 0.24% H: 0.07% C: -0.1%
enhertu her2 granted review tumors positive

---

CTLA4 (Cytotoxic T-Lymphocyte-Associated Protein 4) Inhibitors Market to grow by USD 2.23 billion between 2023 and 2028, growth Driven by High target affinity and specificity of CTLA4 inhibitors - Technavio
Published: 2024-01-26 (Crawled : 02:00) - prnewswire.com
XLO | $1.09 -5.22% -5.5% 250K |

Professional, Scientific, and T...

| 71.88% | O: 4.69% H: 4.55% C: -2.99%
AZNCF | News | $136.2 -4.19% 1.7K |

Health Technology

| 5.07% | O: 2.92% H: 1.06% C: -3.05%
BNTX | News | $88.01 1.38% 1.36% 390K |

Health Technology

| -9.17% | O: -1.35% H: 0.12% C: -0.83%
AZN | News | $70.12 2.29% 2.24% 4.8M |

Health Technology

| 4.64% | O: 1.07% H: 0.1% C: -0.94%
AGEN A | $5.78 8.85% 7.97% 900K |

Health Technology

| 861.99% | O: 3.13% H: 11.02% C: 7.11%
protein growth market

---

Tyrosine Kinase Inhibitors Market to Grow at a CAGR of 8.42% between 2023 to 2028; Industry Trends, Driving Forces, Challenges & Market Forecast | Technavio
Published: 2024-01-25 (Crawled : 11:00) - prnewswire.com
AZNCF | News | $136.2 -4.19% 1.7K |

Health Technology

| 5.16% | O: -1.23% H: 1.34% C: 1.34%
NVSEF | News | $93.6375 6.88% 82K |

Health Technology

| -12.74% | O: -3.67% H: 0.0% C: 0.0%
NVS | News | $95.12 0.81% -1.18% 2.4M |

Health Technology

| -11.88% | O: -0.44% H: 0.19% C: -0.08%
ABBV | News | $167.89 0.89% 0.0% 5.6M |

Health Technology

| 0.45% | O: -1.92% H: 0.0% C: 0.0%
AZN | News | $70.12 2.29% 2.24% 4.8M |

Health Technology

| 5.3% | O: -0.14% H: 0.77% C: 0.77%
market

---

Social Networking Market size to increase by USD 163.6 billion between 2022-2027, The increased Internet penetration to drive growth - Technavio
Published: 2024-01-24 (Crawled : 06:00) - prnewswire.com
AZNCF | News | $136.2 -4.19% 1.7K |

Health Technology

| 2.84% | O: -0.42% H: 0.0% C: -1.8%
ABT | News | $107.07 -0.2% 0.0% 4.9M |

Health Technology

| -6.77% | O: -3.45% H: 0.0% C: 0.0%
AZN | News | $70.12 2.29% 2.24% 4.8M |

Health Technology

| 5.06% | O: -0.03% H: 0.29% C: -0.19%
internet growth market

---

Over-The-Counter Drug Market to Grow by USD 58.54 billion from 2022 to 2027, Abbott Laboratories, Achelios Therapeutics Inc., AstraZeneca Plc, Bayer AG, BioGaia AB as Key Market Contributors - 17000+ Technavio Reports
Published: 2024-01-24 (Crawled : 05:00) - prnewswire.com
RBGPF | News | $51.75 6.46% 3.6K |

Consumer Non-Durables

| -26.92% | O: -1.75% H: 0.0% C: 0.0%
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| -10.09% | O: -3.01% H: 0.69% C: -0.75%
AZNCF | News | $136.2 -4.19% 1.7K |

Health Technology

| 2.84% | O: -0.42% H: 0.0% C: -1.8%
RBGLY | News | $10.35 -2.05% 500K |

Manufacturing

| -25.26% | O: -0.35% H: 0.07% C: -0.14%
NVS | News | $95.12 0.81% -1.18% 2.4M |

Health Technology

| -12.03% | O: 0.22% H: 0.43% C: -0.39%
GSK | News | $40.59 2.11% -0.36% 3.8M |

Health Technology

| 3.34% | O: 0.48% H: 0.66% C: -1.11%
ABT | News | $107.07 -0.2% 0.0% 4.9M |

Health Technology

| -6.77% | O: -3.45% H: 0.0% C: 0.0%
SNY | News | $47.125 1.78% 1.75% 2.1M |

Health Technology

| -7.6% | O: 0.92% H: 0.0% C: 0.0%
AZN | News | $70.12 2.29% 2.24% 4.8M |

Health Technology

| 5.06% | O: -0.03% H: 0.29% C: -0.19%
drug astrazeneca key therapeutics market

---

USD 948.01 million Growth Opportunity in Dental X-Ray Market 2022-2027, 7.75% YOY Growth Expected in 2023 - Technavio
Published: 2024-01-24 (Crawled : 05:00) - prnewswire.com
AZNCF | News | $136.2 -4.19% 1.7K |

Health Technology

| 2.84% | O: -0.42% H: 0.0% C: -1.8%
ABT | News | $107.07 -0.2% 0.0% 4.9M |

Health Technology

| -6.77% | O: -3.45% H: 0.0% C: 0.0%
XRAY | $30.37 -0.43% -0.43% 4.2M |

Health Technology

| -14.43% | O: 0.45% H: 0.0% C: -2.75%
AZN | News | $70.12 2.29% 2.24% 4.8M |

Health Technology

| 5.06% | O: -0.03% H: 0.29% C: -0.19%
expected million dental growth market

---

Hospital Infection Therapeutics Market is to grow by USD 3.10 billion, Special drug designations to boost growth - Technavio
Published: 2024-01-23 (Crawled : 09:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510 |

Health Technology

| 1.0% | O: -2.34% H: 0.43% C: 0.43%
AZNCF | News | $136.2 -4.19% 1.7K |

Health Technology

| 1.8% | O: -2.16% H: 1.17% C: 1.17%
NVSEF | News | $93.6375 6.88% 82K |

Health Technology

| -12.34% | O: 0.46% H: 0.0% C: 0.0%
VTRS | News A | $11.235 -0.13% -0.13% 5.1M |

Health Technology

| -3.35% | O: 0.17% H: 1.33% C: 0.94%
NVS | News | $95.12 0.81% -1.18% 2.4M |

Health Technology

| -12.63% | O: -0.96% H: 0.3% C: 0.28%
GSK | News | $40.59 2.11% -0.36% 3.8M |

Health Technology

| 2.68% | O: -0.76% H: 0.38% C: 0.13%
ABBV | News | $167.89 0.89% 0.0% 5.6M |

Health Technology

| 2.28% | O: 0.37% H: 0.0% C: 0.0%
ABT | News | $107.07 -0.2% 0.0% 4.9M |

Health Technology

| -6.84% | O: -0.07% H: 0.0% C: 0.0%
SNY | News | $47.125 1.78% 1.75% 2.1M |

Health Technology

| -9.5% | O: -2.05% H: 0.0% C: 0.0%
AZN | News | $70.12 2.29% 2.24% 4.8M |

Health Technology

| 4.45% | O: -1.27% H: 0.8% C: 0.69%
drug hospital infection therapeutics growth market

---

Global Respiratory Disease Vaccine Market Set for Growth, Fueled by Aging Populations and Vaccine Mandates - Trends, Opportunities, and Forecasts, 2018-2028F
Published: 2024-01-22 (Crawled : 17:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| -8.68% | O: 1.71% H: 0.0% C: -0.15%
AZNCF | News | $136.2 -4.19% 1.7K |

Health Technology

| 5.26% | O: 2.63% H: 0.8% C: 0.75%
JNJ | News | $149.12 0.82% 0.0% 9.3M |

Health Technology

| -7.38% | O: 0.6% H: 0.0% C: 0.0%
SNY | News | $47.125 1.78% 1.75% 2.1M |

Health Technology

| -9.69% | O: -0.21% H: 0.0% C: 0.0%
AZN | News | $70.12 2.29% 2.24% 4.8M |

Health Technology

| 5.4% | O: 1.8% H: 0.14% C: -0.89%
disease vaccine respiratory global set market

---

USD 10.40 billion growth in Vascular Endothelial Market between 2022 and 2027, The strategic alliances and collaborations are notably driving market growth-17,000+ Technavio Research Reports
Published: 2024-01-22 (Crawled : 05:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| -8.68% | O: 1.71% H: 0.0% C: -0.15%
AZNCF | News | $136.2 -4.19% 1.7K |

Health Technology

| 5.26% | O: 2.63% H: 0.8% C: 0.75%
NVSEF | News | $93.6375 6.88% 82K |

Health Technology

| -11.11% | O: 1.4% H: 0.0% C: 0.0%
VTRS | News A | $11.235 -0.13% -0.13% 5.1M |

Health Technology

| -1.32% | O: -0.18% H: 2.37% C: 2.28%
NVS | News | $95.12 0.81% -1.18% 2.4M |

Health Technology

| -12.44% | O: 0.12% H: 0.39% C: 0.1%
ABBV | News | $167.89 0.89% 0.0% 5.6M |

Health Technology

| 2.86% | O: 0.57% H: 0.0% C: 0.0%
SNY | News | $47.125 1.78% 1.75% 2.1M |

Health Technology

| -9.69% | O: -0.21% H: 0.0% C: 0.0%
AZN | News | $70.12 2.29% 2.24% 4.8M |

Health Technology

| 5.4% | O: 1.8% H: 0.14% C: -0.89%
AMGN | News | $271.98 1.13% 1.12% 2.1M |

Health Technology

| -11.66% | O: 0.29% H: 1.12% C: 0.47%
research growth market

---

Antibody Therapeutics Market Size to Grow USD 364180 Million by 2029 at a CAGR of 11% | Valuates Reports
Published: 2024-01-21 (Crawled : 16:20) - prnewswire.com
JNJ | News | $149.12 0.82% 0.0% 9.3M |

Health Technology

| Email alert Add to watchlist
AZNCF | News | $136.2 -4.19% 1.7K |

Health Technology

| Email alert Add to watchlist
AZN | News | $70.12 2.29% 2.24% 4.8M |

Health Technology

| Email alert Add to watchlist
antibody million therapeutics market

---

Global Orphan Drugs Market Research Report 2023: Market to Reach $415.2 Billion by the End of 2028 - Premium Pricing of Orphan Drugs and Increasing Collaborations/Licensing Agreements Bolsters Growth
Published: 2024-01-17 (Crawled : 20:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| -9.12% | O: 0.1% H: 0.76% C: 0.76%
AZNCF | News | $136.2 -4.19% 1.7K |

Health Technology

| 3.53% | O: 1.06% H: 0.0% C: -2.34%
NVSEF | News | $93.6375 6.88% 82K |

Health Technology

| -11.28% | O: 0.0% H: 0.0% C: 0.0%
ALPMY | News | $9.5 -1.11% 1M |

Manufacturing

| -18.76% | O: -0.6% H: 0.34% C: 0.34%
NVS | News | $95.12 0.81% -1.18% 2.4M |

Health Technology

| -12.46% | O: -0.78% H: 0.59% C: 0.57%
JNJ | News | $149.12 0.82% 0.0% 9.3M |

Health Technology

| -6.96% | O: -0.21% H: 0.0% C: 0.0%
ABBV | News | $167.89 0.89% 0.0% 5.6M |

Health Technology

| 3.61% | O: -0.54% H: 1.55% C: 1.33%
SNY | News | $47.125 1.78% 1.75% 2.1M |

Health Technology

| -10.39% | O: -1.1% H: 1.63% C: 1.59%
AZN | News | $70.12 2.29% 2.24% 4.8M |

Health Technology

| 5.86% | O: -0.51% H: 1.33% C: 0.93%
report reach research global growth market

---

Gainers vs Losers

75%

25%

Top 10 Gainers

MTTR | News M | $4.78 174.71% 63.6% 72M |

AGBA | $2.565 105.2% 51.27% 200M |

Finance

MLEC | $2.44 74.29% 42.62% 78M |

n/a

EDBL | News | $6.28 67.02% 40.13% 16M |

ATGL | $2.91 48.81% 32.8% 180K |

ZAPP | $0.2175 47.16% 32.05% 16M |

n/a

ONFO | $0.6075 38.38% 27.74% 7.3M |

n/a

VIVK | $1.48 38.32% 27.7% 530K |

Professional, Scientific, and T...

MNTS | $0.5 35.69% 26.3% 4.8M |

SDIG A | $3.635 35.13% 26.0% 1M |

---

Your saved searches

---